山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (1): 64-68.doi: 10.6040/j.issn.1673-3770.0.2013.268

• 论著 • 上一篇    下一篇

络治法对STZ诱导的糖尿病大鼠视网膜血管消化铺片中VCAM-1表达的影响

马栋, 郭承伟   

  1. 山东中医药大学附属医院眼科, 山东 济南 250011
  • 收稿日期:2013-09-22 出版日期:2015-02-16 发布日期:2015-02-16
  • 通讯作者: 郭承伟。E-mail:guocw12009@163.com E-mail:guocw12009@163.com
  • 作者简介:马栋。E-mail:adong79@163.com
  • 基金资助:
    山东省自然科学基金(ZR2012HM028)

Collaterals therapy influences the expression of VCAM-1 in the retinal capillary wall of STZ-induced diabetic rats

MA Dong, GUO Cheng-wei   

  1. Department of Ophthalmology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, Shandong, China
  • Received:2013-09-22 Online:2015-02-16 Published:2015-02-16

PDF (PC)

926

被引次数

3

摘要： 目的 观察络治法对链佐脲菌素(STZ)诱导的糖尿病大鼠视网膜毛细血管消化铺片中血管细胞黏附分子-1(VCAM-1)表达的影响,探讨络治法对糖尿病视网膜病变微血管损伤的保护作用及机制。方法 将60只雌性Wistar大鼠随机分成空白组、模型组、对照组及络治组。除空白组不做处理外,其余各组均制作糖尿病大鼠模型并按方案给药。给药24周后每组大鼠取双侧眼球做视网膜血管消化铺片,右眼PAS染色做形态学观察,左眼免疫荧光染色法测定VCAM-1在血管壁中的表达。结果 PAS染色结果显示,络治组糖尿病大鼠视网膜毛细血管在管径粗细、局部扩张程度、扭曲聚集程度等方面较对照组及模型组有明显改善,且络治组大鼠毛细血管管壁周细胞的丢失明显减少,组间比较有统计学差异(P<0.05)。免疫荧光染色显示,络治组视网膜血管壁中VCAM-1呈较少的表达,组间比较有统计学差异(P<0.05)。结论 络治法能够抑制VCAM-1在糖尿病视网膜毛细血管壁中的表达,有效减轻高血糖引起的视网膜微血管损伤,改善糖尿病视网膜微血管的结构与机能。

关键词: 大黄虫丸, 糖尿病视网膜病变, 络治法, 大鼠, 血管细胞黏附分子-1

Abstract: Objective To observe the expression of vascular cell adhesion molecule -1 (VCAM-1) in the retinal digest preparations of streptozotocin (STZ)-induced diabetic rats treated with collaterals therapy, and to investigate the protective effects and mechanism of collaterals therapy on diabetic retinopathy microvascular injury. Methods Sixty female Wistar rats were randomly divided into 4 groups including blank group, model group, control group and collaterals therapy group. All except the blank group rats were made into models of diabetic rats and treated according to the scheme. After 24 weeks each rat's bilateral eyes were made into retinal vascular digest preparations. The right eye was treated by PAS staining for morphological observation and the left eye by immunofluorescence staining for determining the VCAM-1 expression in the vessel wall. Results PAS staining showed that collaterals therapy group had obvious improvement on morphological changes such as vessel diameter, local expansion, vascular twist and so on. However, retinal pericyte damage of collaterals therapy group was significantly suppressed (P<0.05). Immunofluorescence staining showed that VCAM-1 in collaterals therapy group had less expression than in the other groups (P<0.05). Conclusion Collaterals therapy can inhibit the expression of VCAM-1 in diabetic retinal capillary wall, effectively alleviate retinal microvascular damage caused by hyperglycemia, and improve diabetic retinal microvascular structure and function.

Key words: Rhubarb eupolyphaga pills, Diabetic retinopathy, Vascular cell adhesion molecule-1, Collaterals therapy, Rats

中图分类号: 

  • R574
[1] Chun-Shen Li, Rong Miao, Qing Cai, et al. The role of ICAM-1 and VCAM-1 in diabetic retinopathy[J]. Int Eye Sci, 2012, 12(1):1-3.
[2] Gustavsson C, Agardh C D, Zetterqvist A V, et al. Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia[J]. PLoS One, 2010, 5(9):e12699.
[3] 徐叔云,卞如濂,陈修,等.药理实验方法学[M].3版.北京:人民卫生出版社, 1982
[4] 潘琳,周水平,蔡晓频,等.糖尿病大鼠视网膜血管铺片技术的改进及形态学观察[J].中国组织化学与细胞化学杂志, 2001, 10(4):456-458.
[5] 雷燕,王永炎,黄启福.论瘀毒阻络是络病形成的病理基础[J].北京中医药大学学报,1999,22(2):8-10. LEI Yan, WANG Yongyan, HUANG Qifu. Pathologic basis of collateral disease formation[J]. Journal of Beijing University of TCM, 1999, 22(2):8-10.
[6] 江玉娟,司秋菊,张艳慧,等.大黄蜇虫丸对动脉粥样硬化大鼠核因子-κB蛋白表达的影响[J].中国老年学杂志,2011,31(1):113-115.
[7] 成家茂,潘志恒,陈海燕.大黄虫丸的现代功用及作用机制[J].云南中医中药杂志,2009,30(2):67-68.
[8] 李文琍,吴诗品.大黄虫丸治疗慢性肝炎肝纤维化的临床疗效观察[J].中国药房,2008,19(21):1658-1660. LI Wenli, WU Shipin. Clinical efficacy of Dahuang Zhechong Pill on chronic hepatitis with hepatic fibrosis[J]. China Pharmacy, 2008, 19(21):1658-1660.
[9] 徐斌.刺络放血疗法的血管生物学基础[J].中国临床康复,2004,8(24):5126-5127.
[10] 张慧敏,费宇彤,时宇静,等.针刺"百会""太阳"改善局灶性脑缺血脑微血管内皮细胞功能的动态观察[J].针刺研究,2006,31(2):67. ZHANG Huimin, FEI Yutong, SHI Yujing, et al. Effects of acupuncture of "Baihui"(GV 20) and"Taiyang"(EX-HN 5) on functions of vascular endothelial cells in cerebral ischemia injury rats[J]. Acupuncture Research, 2006, 31(2):67.
[11] Goldberg R B. Cytokine and cyokine-like inflammation markers,endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications[J]. Clin Endocrinal Metab, 2009, 94(9):3171-3182.
[12] 李凤鸣.中华眼科学[M].2版.北京:人民卫生出版社, 2004: 2232-2233.
[1] 赵娟,焦万珍,赵博军. UWFSS-OCTA检测糖尿病视网膜病变微循环的变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 80-86.
[2] 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[3] 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[4] 常威威,焦万珍,崔艳艳,赵杰,刘兆强,赵博军. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 130-136.
[5] 何静,雷春燕,张美霞. 糖化血红蛋白变异指数与糖尿病视网膜病变严重程度的相关性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 34-40.
[6] 伦英俊,陈晨,高宏程,范清琳,邰仁清. TLR4/NF-κB通道在糖尿病视网膜病变中的作用[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 163-168.
[7] 唐慧新,李景景,邹红. 阈值下微脉冲激光光凝作用机制及临床应用[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 143-148.
[8] 刘通,林玮,冯萌,杨依,刘婷婷,张敏. 基于网络药理学分析小檗碱在免疫微环境中对糖尿病视网膜病变的作用及实验验证[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 94-104.
[9] 王娇娇,李苗宋宗明. 糖尿病视网膜病变的机制和细胞模型研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 93-99.
[10] 王惠, 王俊,孙乙,于腾飞,朱玉广, 朱艳. 玻璃体腔注射HGF-MSCs对糖尿病大鼠视网膜HGF表达的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 72-77.
[11] 刘志高,王淑雅,韩旭光,王玉,李志伟,马爱华,赵博军. 增殖性糖尿病视网膜病变术前玻璃体腔应用阿柏西普的时机及其疗效观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 99-103.
[12] 刘建波,张环. 超声乳化联合玻璃体腔药物注射治疗白内障合并糖尿病性黄斑水肿[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 99-104.
[13] 李宝华,刘平,王新. β-榄香烯影响糖尿病大鼠视网膜中IL-1β、ICAM-1表达分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 111-114.
[14] 刘万智,陈珺,樊长春. 康柏西普治疗增生性糖尿病视网膜病变[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 88-91.
[15] 周学义,李一鸣,王美菊,张苑苑,张历浊. 25+微创玻璃体视网膜手术联合玻璃体腔注射雷珠单抗治疗增生型糖尿病视网膜病变的临床观察[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 87-89.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发